Novocure's device has shown superiority over immunotherapy, but not chemotherapy. It will be important to examine how Novocure dealt with this phenomenon in its enrollment, he said. Kumar has a 42 price target on NVCR stock. He expects the lung cancer market to be worth under $700 million for Novocure.
What are nvcr share price targets?
Their NVCR share price targets range from $15.00 to $51.00. On average, they anticipate the company's stock price to reach $33.25 in the next year. This suggests a possible upside of 119.8% from the stock's current price. View analysts price targets for NVCR or view top-rated stocks among Wall Street analysts.
Does Novocure Ltd (nvcr) pay a dividend?
No significant news for in the past two years. NVCR is not currently paying a regular dividend. View the latest Novocure Ltd. (NVCR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
